Levena Biopharma

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

Levena Biopharma operates as a global contract research and development organization focused on antibody drug conjugates (ADCs). It provides discovery-to-clinic support and specializes in conjugation, with capabilities spanning small- and large-scale proof-of-concept work and comprehensive ADC characterization using advanced analytical methods. The company maintains an in-house portfolio of linker, payload, and site-specific conjugation technologies, enabling the development of mechanistically defined ADCs with a focus on safety, efficacy, and reproducible performance for clients' targeted biomolecular carriers.

Headquartered in San Diego, California, with additional operations in Suzhou, Levena positions itself within the pharmaceutical manufacturing and bioconjugation landscape to support drug developers pursuing precision medicine for unmet clinical needs. Its service model targets biotechnology and pharmaceutical researchers seeking access to specialized ADC solutions and platform capabilities, including collaboration opportunities to advance antibody- or protein- and nucleic-acid–based targeting strategies. The company has a history linked to the Concortis portfolio and operatively functions as a subsidiary with a stated mission of collaboratively advancing conjugates for therapeutic potential and clinical progress.

Sign up for free to view info

Email Format Employee directory